Syntimmune, Inc. announced it raised $18 Million in an initial filing from an offering of $50 Million

Jun 28, 2017•over 8 years ago

Amount Raised

$18 Million

New YorkBiotechnology

Company Information

Company

Syntimmune, Inc.

Location

257 PARK AVENUE SOUTH

New York, New York, United States

About

NY-based clinical-stage biotechnology company

7 contacts

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech